Cite
HARVARD Citation
Amode, R. et al. (2017). Anti-programmed cell death protein 1 tolerance and efficacy after ipilimumab immunotherapy. Melanoma research. 27 (2), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Amode, R. et al. (2017). Anti-programmed cell death protein 1 tolerance and efficacy after ipilimumab immunotherapy. Melanoma research. 27 (2), p. . [Online].